Harbor Investment Advisory LLC Cuts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Harbor Investment Advisory LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 32,447 shares of the healthcare conglomerate's stock after selling 2,118 shares during the period. UnitedHealth Group accounts for approximately 1.6% of Harbor Investment Advisory LLC's portfolio, making the stock its 9th biggest position. Harbor Investment Advisory LLC's holdings in UnitedHealth Group were worth $16,994,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the business. NewSquare Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in UnitedHealth Group in the fourth quarter valued at about $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group in the fourth quarter valued at about $30,000. Finally, Promus Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter worth about $32,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $5.29 during midday trading on Thursday, hitting $295.09. The stock had a trading volume of 7,135,363 shares, compared to its average volume of 6,913,360. The company's 50-day moving average price is $418.00 and its 200-day moving average price is $488.12. The company has a market capitalization of $267.69 billion, a P/E ratio of 19.04, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the previous year, the firm posted $6.91 earnings per share. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Buying and Selling

In other UnitedHealth Group news, Director Kristen Gil bought 3,700 shares of UnitedHealth Group stock in a transaction on Thursday, May 15th. The shares were purchased at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the acquisition, the director now directly owns 3,818 shares of the company's stock, valued at $1,035,327.06. The trade was a 3,135.59% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO John F. Rex bought 17,175 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The shares were acquired at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the acquisition, the chief financial officer now directly owns 203,796 shares in the company, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 109,408 shares of company stock worth $31,607,768 in the last three months. 0.33% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages have issued reports on UNH. Wolfe Research lowered their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 20th. Mizuho lowered their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. Argus lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. Hsbc Global Res lowered shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Finally, Wells Fargo & Company decreased their price objective on shares of UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have assigned a buy rating to the company's stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus price target of $428.43.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.